Cart
Shopping cart

Wai Yee Wong

Zinzino Independent Partner

Velkommen! Jeg er din personlige uavhengige partner og jeg er her for å veilede deg på din helsereise.

Press releases - torsdag 7. mars 2019 12.00 CET

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT FEBRUARY 2019

STRONG SALES GROWTH DURING FEBRUARY; ZINZINO BASED REVENUE INCREASED 21% AND THE TOTAL GROUP REVENUE WITH 18% COMPARED WITH THE PREVIOUS YEAR.

The revenue for Zinzino's sales markets increasing by 21% to SEK 50.1 (41.4) million. Higher share of internal production during the month meant that Faun Pharma's external sales decreased by 22% and amounted to SEK 2.9 (3.7) million. Overall, the Group increased revenues by 18% to SEK 53.0 (45.1) million compared with the previous year.

Accumulated revenues for January-February increased with 16% to 106,5 (91,9) MSEK compared with the previous year.

Revenues distributed as follows:

Regions, MSEK Febr-19 Febr-18 Change 2019 2018 Change
Nordic Countries 29.8 31.2 -4% 60.7 61.7 -2%
Baltic States 4.7 3.6 29% 9.0 7.3 23%
Rest of Europa 13.6 5.1 168% 26.6 9.4 182%
North America 2.0 1.5 29% 3.7 3.2 16%
Zinzino 50.1 41.4 21% 100.0 81.6 23%
Faun Pharma 2.9 3.7 -22% 6.5 10.3 -37%
Zinzino Group 53.0 45.1 18% 106,5 91.9 16%

  
For more information please contact:
Dag Bergheim Pettersen, CEO Zinzino, tel. +47 (0) 932 25 700 www.zinzino.se

Pictures for free publication:
Marcus Tollbom, tel. +46 (0) 70-190 03 12

Certified Adviser:
Erik Penser Bank Aktiebolag: +46 (0)8 463 83 00 Email: certifiedadviser@penser.se


Tags
Zinzino